111 related articles for article (PubMed ID: 8912831)
1. Potential utility of p53 immunopositivity in differentiation of adenocarcinomas from reactive epithelial atypias of the lung.
Cagle PT; Fraire AE; Greenberg SD; Cox A; Brown RW
Hum Pathol; 1996 Nov; 27(11):1198-203. PubMed ID: 8912831
[TBL] [Abstract][Full Text] [Related]
2. p53 immunostaining in the differentiation of reactive processes from malignancy in pleural biopsy specimens.
Cagle PT; Brown RW; Lebovitz RM
Hum Pathol; 1994 May; 25(5):443-8. PubMed ID: 8200637
[TBL] [Abstract][Full Text] [Related]
3. p53 immunostaining in the differentiation of inflammatory pseudotumor from sarcoma involving the lung.
Ledet SC; Brown RW; Cagle PT
Mod Pathol; 1995 Apr; 8(3):282-6. PubMed ID: 7617655
[TBL] [Abstract][Full Text] [Related]
4. Expression of Fhit, cell adhesion molecules and matrix metalloproteinases in atypical adenomatous hyperplasia and pulmonary adenocarcinoma.
Kerr KM; MacKenzie SJ; Ramasami S; Murray GI; Fyfe N; Chapman AD; Nicolson MC; King G
J Pathol; 2004 Jun; 203(2):638-44. PubMed ID: 15141378
[TBL] [Abstract][Full Text] [Related]
5. Bronchioloalveolar carcinoma: diagnostic pitfalls and immunocytochemical contribution.
Saleh HA; Haapaniemi J; Khatib G; Sakr W
Diagn Cytopathol; 1998 Apr; 18(4):301-6. PubMed ID: 9557268
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of percentage of bronchioloalveolar pattern in adenocarcinomas of the lung.
Castro CY; Coffey DM; Medeiros LJ; Cagle PT
Ann Diagn Pathol; 2001 Oct; 5(5):274-84. PubMed ID: 11598855
[TBL] [Abstract][Full Text] [Related]
7. p53 gene product in pleural effusions. Practical use in distinguishing benign from malignant cells.
Mullick SS; Green LK; Ramzy I; Brown RW; Smith D; Gondo MM; Cagle PT
Acta Cytol; 1996; 40(5):855-60. PubMed ID: 8842156
[TBL] [Abstract][Full Text] [Related]
8. Proliferative potential and p53 overexpression in precursor and early stage lesions of bronchioloalveolar lung carcinoma.
Kitamura H; Kameda Y; Nakamura N; Nakatani Y; Inayama Y; Iida M; Noda K; Ogawa N; Shibagaki T; Kanisawa M
Am J Pathol; 1995 Apr; 146(4):876-87. PubMed ID: 7717455
[TBL] [Abstract][Full Text] [Related]
9. [The relationship between adenomatous hyperplasia of alveolar epithelium and bronchioalveolar carcinoma].
Zhang L; Okada Y
Zhonghua Zhong Liu Za Zhi; 1994 Mar; 16(2):141-3. PubMed ID: 7924866
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of p53 mutations in bronchioloalveolar carcinoma and conventional pulmonary adenocarcinoma.
Wang X; Rao MS; Yeldandi AV
Mod Pathol; 1995 Dec; 8(9):919-23. PubMed ID: 8751332
[TBL] [Abstract][Full Text] [Related]
11. p53 gene alteration in atypical epithelial lesions and carcinoma in patients with idiopathic pulmonary fibrosis.
Kawasaki H; Ogura T; Yokose T; Nagai K; Nishiwaki Y; Esumi H
Hum Pathol; 2001 Oct; 32(10):1043-9. PubMed ID: 11679937
[TBL] [Abstract][Full Text] [Related]
12. P63 in pulmonary epithelium, pulmonary squamous neoplasms, and other pulmonary tumors.
Wang BY; Gil J; Kaufman D; Gan L; Kohtz DS; Burstein DE
Hum Pathol; 2002 Sep; 33(9):921-6. PubMed ID: 12378518
[TBL] [Abstract][Full Text] [Related]
13. Influence of cigarette smoking on histological subtypes of stage I lung adenocarcinoma.
Maeda R; Ishii G; Yoshida J; Hishida T; Nishimura M; Nagai K
J Thorac Oncol; 2011 Apr; 6(4):743-50. PubMed ID: 21325977
[TBL] [Abstract][Full Text] [Related]
14. Distribution of basal/myoepithelial markers in benign and malignant bronchioloalveolar proliferations of the lung.
Saad RS; Liu YL; Silverman JF
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):219-25. PubMed ID: 20065853
[TBL] [Abstract][Full Text] [Related]
15. p53 expression in normal and dysplastic bronchial epithelium and in lung carcinomas.
Walker C; Robertson LJ; Myskow MW; Pendleton N; Dixon GR
Br J Cancer; 1994 Aug; 70(2):297-303. PubMed ID: 7914423
[TBL] [Abstract][Full Text] [Related]
16. Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression.
Kerr KM; Carey FA; King G; Lamb D
J Pathol; 1994 Dec; 174(4):249-56. PubMed ID: 7884586
[TBL] [Abstract][Full Text] [Related]
17. Argyrophilic nucleolar-organizer region counts and DNA status in bronchioloalveolar epithelial hyperplasia and adenocarcinoma of the lung.
Nakanishi K; Hiroi S; Kawai T; Suzuki M; Torikata C
Hum Pathol; 1998 Mar; 29(3):235-9. PubMed ID: 9496825
[TBL] [Abstract][Full Text] [Related]
18. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction.
Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O
Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of pulmonary atypical alveolar cell hyperplasia in an autopsy population: a study of 100 cases.
Sterner DJ; Mori M; Roggli VL; Fraire AE
Mod Pathol; 1997 May; 10(5):469-73. PubMed ID: 9160312
[TBL] [Abstract][Full Text] [Related]
20. Prognostic implications of calbindin-D28k expression in lung cancer: analysis of 452 cases.
Castro CY; Stephenson M; Gondo MM; Medeiros LJ; Cagle PT
Mod Pathol; 2000 Jul; 13(7):808-13. PubMed ID: 10912942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
